JENBURKT PHARMACEUTICAL L (JENBURPH) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1985, Jenburkt Pharmaceuticals Ltd manufactures and markets branded Pharmaceuticals and health care products[1]

JENBURPHUpdated 18 Aug 2026, 2:25

Jenburkt Pharmaceutical L

Market Cap

₹463Cr.

Current Price

₹1,050

High / Low

₹1,321/944

Stock P/E

13.0

ROE20.2%
ROCE27.0%
Book Value₹446
Face Value₹10.0
Dividend Yield1.71%

About

Incorporated in 1985, Jenburkt Pharmaceuticals Ltd manufactures and markets branded Pharmaceuticals and health care products[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days322332406855474545505053
Inventory Days10710912873991209211592103109154
Days Payable5444724466585683677510091
Cash Conversion Cycle858889691011178377707859115
Working Capital Days-11610253532171631363141
ROCE %42%40%39%42%37%26%24%26%27%26%27%27%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 August 2026 at 2:25


Designed & Shipped by Harshit Bansal